- ICH GCP
- USA klinikai vizsgálatok nyilvántartása
- Klinikai vizsgálat NCT03200366
Comparing Interventions to Increase Colorectal Cancer Screening
Comparing Interventions to Increase Colorectal Cancer Screening in Low-Income and Minority Patients
The purpose of this study is to test different approaches to help people understand the purpose of colorectal cancer (CRC) screening, two screening test options available, and the barriers to screening so they can make informed decisions about CRC screening. Participants will be randomly assigned to one of three groups: (1) one group will receive a tailored digital video disc (DVD) in the mail; (2) another group will receive the mailed DVD plus telephone calls from a patient navigator; and (3) the third group will receive the care normally provided by the healthcare system's endoscopy department.
The investigators hypothesize the following: (1) participants who receive the tailored DVD plus the patient navigation intervention will have higher rates of CRC screening with the fecal immunochemical test (FIT), colonoscopy, or either screening test compared to those who receive the tailored DVD alone; (2) participants who receive either intervention (DVD only or DVD plus patient navigation) will have higher rates of CRC screening with FIT, colonoscopy, or either screening test than those who receive usual care; and (3) participants who receive either intervention who complete colonoscopy will have better quality of bowel preparation, less anxiety about the procedure, and greater satisfaction with the colonoscopy experience than those who receive usual care.
A tanulmány áttekintése
Állapot
Körülmények
Beavatkozás / kezelés
Részletes leírás
Tanulmány típusa
Beiratkozás (Tényleges)
Fázis
- Nem alkalmazható
Kapcsolatok és helyek
Tanulmányi helyek
-
-
Indiana
-
Indianapolis, Indiana, Egyesült Államok, 46202
- Eskenazi Health
-
Indianapolis, Indiana, Egyesült Államok, 46202
- Indiana University School of Nursing
-
-
Részvételi kritériumok
Jogosultsági kritériumok
Tanulmányozható életkorok
Egészséges önkénteseket fogad
Tanulmányozható nemek
Leírás
Inclusion Criteria:
- Referred for a screening colonoscopy that was not done (i.e, canceled or no show)
Exclusion Criteria:
- Unable to speak, read, and write English
- Personal history of CRC or polyps
- Personal history of conditions that place participants at high risk for CRC such as ulcerative colitis, Crohn's disease, or known hereditary syndromes such as familial adenomatous polyposis or hereditary nonpolyposis colorectal cancer
- Family history of CRC which increases the participant's risk for CRC
- Advised by a health care provider to not have a colonoscopy due to the participant's health
- Speech impairment
- Hearing impairment
- Cognitive impairment
- Vision impairment
Tanulási terv
Hogyan készül a tanulmány?
Tervezési részletek
- Elsődleges cél: Szűrés
- Kiosztás: Véletlenszerűsített
- Beavatkozó modell: Párhuzamos hozzárendelés
- Maszkolás: Nincs (Open Label)
Fegyverek és beavatkozások
Résztvevő csoport / kar |
Beavatkozás / kezelés |
|---|---|
|
Aktív összehasonlító: Tailored DVD
Tailored digital video disc (DVD)
|
A 20 minute tailored DVD titled "Approaches to Colon Testing" is viewed by participants.
It is designed to encourage CRC screening uptake by colonoscopy or FIT by increasing the participant's CRC knowledge and beliefs about the benefits of screening, reducing barriers to screening, and increasing self-efficacy for screening by demonstrating how these tests are performed.
|
|
Aktív összehasonlító: Tailored DVD + Patient Navigation
Tailored digital video disc (DVD) plus Patient Navigation by a population health nurse in the healthcare system
|
A 20 minute tailored DVD titled "Approaches to Colon Testing" is viewed by participants.
It is designed to encourage CRC screening uptake by colonoscopy or FIT by increasing the participant's CRC knowledge and beliefs about the benefits of screening, reducing barriers to screening, and increasing self-efficacy for screening by demonstrating how these tests are performed.
Participants talk by telephone with a Patient Navigator who is a trained nurse.
The Patient Navigator determines if participants viewed the tailored DVD and answers any questions about the content.
The Patient Navigator then provides telephone counseling on CRC and screening tests to: (1) increase knowledge, perceived benefits, and self-efficacy; (2) reduce barriers; (3) enhance access; and (4) provide social support.
|
|
Nincs beavatkozás: Usual Care
Care normally provided by a nurse in the endoscopy department of the healthcare system
|
Mit mér a tanulmány?
Elsődleges eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Participants Completing CRC Screening Per Electronic Medical Record Documentation
Időkeret: 12 months post-baseline interview
|
Number of participants completing CRC screening by any test (defined as colonoscopy or FIT) is measured by electronic medical record review.
Dates that participants had a colonoscopy and dates of FIT analysis are extracted from the electronic medical record.
|
12 months post-baseline interview
|
Másodlagos eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Participants Completing Colonoscopy Per Electronic Medical Record Documentation
Időkeret: 12 months post-baseline interview
|
Number of participants completing a colonoscopy is measured by electronic medical record review (EMR).
Dates that participants completed a colonoscopy are extracted from the EMR.
|
12 months post-baseline interview
|
|
Bowel Preparation Quality Rating Using Boston Bowel Preparation Scale
Időkeret: 12 months post-baseline interview
|
Participants quality of bowel preparation is measured by the endoscopist during their colonoscopy procedure using the Boston Bowel Preparation Scale (BBPS).
BBPS scores the total quality on a 10 point scale from 0-9.
Higher scores indicate better quality of bowel preparation.
|
12 months post-baseline interview
|
|
Participants With Adequate Quality of Bowel Preparation Per Modified Aronchick Rating Scale
Időkeret: 12 months post-baseline interview
|
Participants quality of bowel preparation is measured by the endoscopist during their colonoscopy using a modification of the Aronchick rating scale.
The Aronchick scale rates quality as 1=excellent, 2=good, 3=fair, or 4=poor.
Some endoscopists choose to grade quality more generally as adequate vs. inadequate.
To accommodate this variation, bowel preparation ratings have been dichotomized into adequate (excellent, good, fair, or adequate ratings) vs. inadequate (poor or inadequate ratings).
Adequate is scored as 1 and indicates better quality of bowel preparation than inadequate which is scored as 0.
|
12 months post-baseline interview
|
|
Colonoscopy-Related Procedural Anxiety for Participants Completing a Colonoscopy
Időkeret: 12 months post-baseline interview
|
Colonoscopy-related procedural anxiety is measured by self-report using the 6-item short form of the State Anxiety Scale of the State-Trait Anxiety Inventory.
Each item is scored from 1 to 4 (1=not at all; 4=very much so) with higher scores indicating greater anxiety.
|
12 months post-baseline interview
|
|
Satisfaction With Colonoscopy Experience
Időkeret: 12 months post-baseline interview
|
Satisfaction with the colonoscopy experience is measured by self-report using a single item developed by the research team.
Satisfaction is rated from 1 to 4 where 1=not at all satisfied, 2=a little satisfied, 3=mostly satisfied, and 4=completely satisfied.
Scores range from 1 to 4 with higher scores indicating greater satisfaction.
|
12 months post-baseline interview
|
|
Participants Completing a Fecal Immunochemical Test (FIT) Per Electronic Medical Record Documentation
Időkeret: 12 months post-baseline interview
|
Number of participants completing a FIT is measured by electronic medical record review (EMR).
Dates of FIT analysis are extracted from the EMR.
|
12 months post-baseline interview
|
|
Participants Who Self-Reported Completing CRC Screening
Időkeret: 6-9 months post-baseline interview
|
Number of participants who reported completing CRC screening by any test (defined as colonoscopy or FIT) during the 6 or 9 month post-baseline telephone interview.
|
6-9 months post-baseline interview
|
|
Participants Who Self-Reported Completing a Colonoscopy
Időkeret: 6-9 months post-baseline interview
|
Number of participants who reported completing a colonoscopy during the 6 or 9 month post-baseline telephone interview.
|
6-9 months post-baseline interview
|
|
Participants Who Self-Reported Completing a Fecal Immunochemical Test (FIT)
Időkeret: 6-9 months post-baseline interview
|
Number of participants who reported completing a FIT during the 6 or 9 month post-baseline telephone interview.
|
6-9 months post-baseline interview
|
|
Change in Knowledge of CRC and Screening
Időkeret: 6 months post-baseline interview
|
Change from baseline in knowledge of CRC and screening is measured at 6 months by self-report using a 9-item multidimensional scale.
Each item is scored as 1=correct or 0=incorrect and summed to yield a scale score.
Scores range from 0 to 9 with higher summated scores indicating greater knowledge of CRC and screening tests.
The mean of the 9 items is calculated at baseline and 6 months post-baseline.
Change from baseline equals the mean at 6 months minus the mean at baseline.
Change can range from -9 to 9 with positive values indicating an increase in knowledge.
|
6 months post-baseline interview
|
|
Change in Perceived Risk for CRC
Időkeret: 6 months post-baseline interview
|
Change from baseline in perceived risk for CRC is measured by self-report at 6 months using a 3-item scale.
We ask participants how likely it is that they will get colon cancer sometime during their lifetime, within the next 10 years, and within the next 5 years.
Each item is scored from 1 to 4 (1=very unlikely; 4=very likely).
Higher scores indicate a higher perceived risk for getting CRC.
The mean of the 3 items is calculated at baseline and 6 months.
Change in perceived risk equals the mean at 6 months minus the mean at baseline.
Change can range from -3 to 3 with positive values indicating an increase in perceived risk for getting CRC.
|
6 months post-baseline interview
|
|
Change in Colonoscopy-Related Procedural Anxiety Regardless of Whether or Not Participants Had a Colonoscopy
Időkeret: 6 months post-baseline interview
|
Change from baseline in colonoscopy-related procedural anxiety is measured at 6 months by self-report using the 6-item short form of the State Anxiety Scale of the State-Trait Anxiety Inventory.
Each item is scored from 1 to 4 (1=not at all; 4=very much so) with higher scores indicating greater anxiety.
The mean of the 6 items is calculated at baseline and 6 months post-baseline.
Change from baseline is the mean at 6 months minus the mean at baseline.
Change can range from -3 to 3 with positive values indicating an increase in anxiety.
|
6 months post-baseline interview
|
|
Change in Perceived Benefits of CRC Screening by Colonoscopy
Időkeret: 6 months post-baseline interview
|
Change from baseline in perceived benefits of CRC screening by colonoscopy is measured at 6 months by self-report using a 4-item scale.
Each item is scored from 1 to 4 (1=strongly disagree; 4=strongly agree) and the mean of the 4 items calculated.
Higher mean scores indicate greater perceived benefits of screening by colonoscopy.
Change in perceived benefits equals the mean at 6 months minus the mean at baseline.
Change can range from -3 to 3 with positive values indicating an increase in perceived benefits of screening by colonoscopy.
|
6 months post-baseline interview
|
|
Change in Perceived Barriers to CRC Screening by Colonoscopy
Időkeret: 6 months post-baseline interview
|
Change from baseline in perceived barriers to CRC screening by colonoscopy is measured at 6 months by self-report using a 16-item scale.
Each item is scored from 1 to 4 (1=strongly disagree; 4=strongly agree) and the mean of the 16 items calculated.
Higher mean scores indicate greater perceived barriers to screening by colonoscopy.
Change in perceived barriers equals the mean at 6 months minus the mean at baseline.
Change can range from -3 to 3 with negative values indicating a decrease in perceived barriers to screening by colonoscopy.
|
6 months post-baseline interview
|
|
Change in Perceived Self-Efficacy for CRC Screening by Colonoscopy
Időkeret: 6 months post-baseline interview
|
Change from baseline in perceived self-efficacy for colonoscopy is measured at 6 months by self-report using an 11-item scale.
Each item is scored from 1 to 4 (1=not at all sure; 4=very sure) and the mean of the 11 items calculated.
Higher mean scores indicate greater perceived self-efficacy for screening by colonoscopy.
Change in perceived self-efficacy equals the mean at 6 months minus the mean at baseline.
Change can range from -3 to 3 with positive values indicating an increase in perceived self-efficacy for screening by colonoscopy.
|
6 months post-baseline interview
|
|
Change in Perceived Benefits of CRC Screening by FIT
Időkeret: 6 months post-baseline interview
|
Change from baseline in perceived benefits of CRC screening by FIT is measured at 6 months by self-report using a 3-item scale.
Each item is scored from 1 to 4 (1=strongly disagree; 4=strongly agree) and the mean of the 3 items calculated.
Higher mean scores indicate greater perceived benefits of screening by FIT.
Change in perceived benefits equals the mean at 6 months minus the mean at baseline.
Change can range from -3 to 3 with positive values indicating an increase in perceived benefits for screening by FIT.
|
6 months post-baseline interview
|
|
Change in Perceived Barriers to CRC Screening by FIT
Időkeret: 6 months post-baseline interview
|
Change from baseline in perceived barriers to CRC screening by FIT is measured at 6 months by self-report using a 10-item scale.
Each item is scored from 1 to 4 (1=strongly disagree; 4=strongly agree) and the mean of the 10 items calculated.
Higher mean scores indicate greater perceived barriers to screening by FIT.
Change in perceived barriers equals the mean at 6 months minus the mean at baseline.
Change can range from -3 to 3 with negative values indicating a decrease in perceived barriers to screening by FIT.
|
6 months post-baseline interview
|
|
Change in Perceived Self-Efficacy for CRC Screening by FIT
Időkeret: 6 months post-baseline interview
|
Change from baseline in perceived self-efficacy for CRC screening by FIT is measured at 6 months by self-report using a 7-item scale.
Each item is scored from 1 to 4 (1=not at all sure; 4=very sure) and the mean of the 7 items calculated.
Higher mean scores indicate greater perceived self-efficacy for screening by FIT.
Change in perceived self-efficacy equals the mean at 6 months minus the mean at baseline.
Change can range from -3 to 3 with positive values indicating an increase in perceived self-efficacy for screening by FIT.
|
6 months post-baseline interview
|
Együttműködők és nyomozók
Szponzor
Nyomozók
- Kutatásvezető: Susan M Rawl, PhD,RN, Indiana University
Tanulmányi rekorddátumok
Tanulmány főbb dátumok
Tanulmány kezdete (Tényleges)
Elsődleges befejezés (Tényleges)
A tanulmány befejezése (Tényleges)
Tanulmányi regisztráció dátumai
Először benyújtva
Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak
Első közzététel (Tényleges)
Tanulmányi rekordok frissítései
Utolsó frissítés közzétéve (Tényleges)
Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak
Utolsó ellenőrzés
Több információ
A tanulmányhoz kapcsolódó kifejezések
Kulcsszavak
További vonatkozó MeSH feltételek
Egyéb vizsgálati azonosító számok
- 1605880142
- IHS-1507-31333 (Egyéb támogatási/finanszírozási szám: Patient-Centered Outcomes Research Institute (PCORI))
Terv az egyéni résztvevői adatokhoz (IPD)
Tervezi megosztani az egyéni résztvevői adatokat (IPD)?
IPD terv leírása
IPD megosztási időkeret
IPD-megosztási hozzáférési feltételek
Az IPD megosztását támogató információ típusa
- STUDY_PROTOCOL
- NEDV
Gyógyszer- és eszközinformációk, tanulmányi dokumentumok
Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz
Egy amerikai FDA által szabályozott eszközterméket tanulmányoz
Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .
Klinikai vizsgálatok a Colorectalis rák
-
Ohio State University Comprehensive Cancer CenterMég nincs toborzásAnatómiai stádiumú emlőrák AJCC v8 | Anatómiai Stage II Breast Cancer AJCC v8 | Anatómiai Stage III Breast Cancer AJCC v8 | Anatómiai Stage IV Breast Cancer AJCC v8 | Kemoterápia által kiváltott alopeciaEgyesült Államok
-
National Cancer Institute (NCI)ToborzásStage III Sinonasal Cancer AJCC v8 | Stage IVA Sinonasal Cancer AJCC v8 | IVB stádiumú Sinonasalis rák AJCC v8 | Sinonasalis laphámsejtes karcinómaEgyesült Államok
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH); Rising Tide...ToborzásAnatómiai Stage II Breast Cancer AJCC v8 | Anatómiai Stage III Breast Cancer AJCC v8 | Korai stádiumú emlőkarcinóma | Anatómiai Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8Egyesült Államok
-
City of Hope Medical CenterNational Cancer Institute (NCI)Még nincs toborzásAnatómiai Stage III Breast Cancer AJCC v8 | Anatómiai Stage IV Breast Cancer AJCC v8 | Áttétes hormonreceptor-pozitív emlőkarcinóma | Nem reszekálható hormonreceptor-pozitív emlőkarcinóma | Advanced Hormone Receptor-Positive Breast CarcinomaEgyesült Államok
-
Mayo ClinicNational Institute for Biomedical Imaging and Bioengineering (NIBIB)ToborzásAnatómiai Stage II Breast Cancer AJCC v8 | Anatómiai Stage III Breast Cancer AJCC v8 | Anatómiai Stage IV Breast Cancer AJCC v8 | Helyileg előrehaladott emlőkarcinómaEgyesült Államok
-
University of Michigan Rogel Cancer CenterToborzásAnatómiai stádiumú emlőrák AJCC v8 | Anatómiai Stage II Breast Cancer AJCC v8 | Anatómiai Stage III Breast Cancer AJCC v8 | Anatómiai Stage IV Breast Cancer AJCC v8 | Áttétes emlőkarcinómaEgyesült Államok
-
Mayo ClinicMég nincs toborzásAnatómiai stádiumú emlőrák AJCC v8 | Anatómiai Stage II Breast Cancer AJCC v8 | Anatómiai Stage III Breast Cancer AJCC v8 | Helyileg előrehaladott hormonreceptor-pozitív emlőkarcinómaEgyesült Államok
-
Mayo ClinicNational Cancer Institute (NCI)ToborzásAnatómiai stádiumú emlőrák AJCC v8 | Anatómiai Stage II Breast Cancer AJCC v8 | Anatómiai Stage III Breast Cancer AJCC v8 | Anatómiai Stage IV Breast Cancer AJCC v8 | Mell adenokarcinóma | HER2-pozitív emlőkarcinómaEgyesült Államok
-
Mayo ClinicToborzásAnatómiai Stage II Breast Cancer AJCC v8 | Anatómiai Stage III Breast Cancer AJCC v8 | Áttétes emlőrák | Anatómiai Stage IV Breast Cancer AJCC v8 | Hormonreceptor-pozitív emlőkarcinóma | HER2-negatív emlőrák | Áttétes emlőkarcinóma | HER2 negatív emlőkarcinóma | Hormonreceptor-pozitív emlőrákEgyesült Államok
-
Fred Hutchinson Cancer CenterMég nincs toborzásAnatómiai stádiumú emlőrák AJCC v8 | Anatómiai Stage II Breast Cancer AJCC v8 | Anatómiai Stage III Breast Cancer AJCC v8Egyesült Államok
Klinikai vizsgálatok a Tailored DVD
-
The Miriam HospitalNational Institute of Mental Health (NIMH); Brown University; University of Rochester és más munkatársakBefejezveHIV fertőzések | Szexuális úton terjedő betegségek | HIVEgyesült Államok
-
VA Office of Research and DevelopmentBefejezve
-
The University of Hong KongThe Boys' and Girls' Clubs Association of Hong KongBefejezve
-
Abbott Medical DevicesToborzásMitrális regurgitáció | Szívbillentyű-betegség | Tricuspidalis regurgitációÉsztország, Franciaország, Németország, Olaszország, Spanyolország, Hollandia, Egyesült Államok
-
AmgenBefejezve
-
Case Comprehensive Cancer CenterAmerican Cancer Society, Inc.; Consumer Wellness Solutions; North Carolina Tobacco...BefejezveA dohányzás abbahagyásaEgyesült Államok
-
University of Texas Southwestern Medical CenterAgency for Healthcare Research and Quality (AHRQ)BefejezveMellrák neoplazmák | Tüdő neoplazmák | Vastagbél neoplazmákEgyesült Államok
-
University of RochesterThe Commonwealth Fund; Academic Pediatric AssociationBefejezve
-
Nova Scotia Health AuthorityCapital Health, CanadaBefejezve
-
IRCSS Istituto Dermopatico dell'Immacolata, Fondazione...Ministry of Health, Italy; Centro di Eccellenza per la Cultura e la Ricerca Infermieristica...Befejezve